(HealthDay News) — Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Rosacea
This study of two topical gels is for people who have blotchy, red skin across the face from rosacea. The trial will last for 12 weeks, with four office visits.
The research site is in Plano, Texas.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/rosacea.aspx.
—–
Ulcerative Colitis
This study for people 18 and older will evaluate a once-daily investigational drug for ulcerative colitis. This study will last for 14 months.
The research site is in Sandy, Utah.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/ulcerative_colitis.aspx.
—–
Schizophrenia
This study will evaluate an investigational medication for schizophrenia. Candidates must be 18 to 64 and currently being treated with Zyprexa, Risperdal or Abilify. The research site is in Cherry Hill, N.J.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/schizophrenia.aspx.
—–
Copyright 2011 ClinicalConnection.com. All rights reserved.